Literature DB >> 8527543

Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus.

J Veenstra1, R Schuurman, M Cornelissen, A B van't Wout, C A Boucher, H Schuitemaker, J Goudsmit, R A Coutinho.   

Abstract

We describe the development and persistence of severe immunodeficiency in a previously healthy young woman shortly after she was deliberately injected with blood that was drawn from a patient with AIDS. The heterogenous populations of human immunodeficiency virus (HIV) in donor and recipient were as closely related as those reported in previous cases of proven transmission. The relatively large proportion of non-syncytium-inducing (NSI) clones in the recipient suggests a selective but not complete suppression of syncytium-inducing (SI) viruses. The continuous presence of SI viruses might explain the severe immunosuppression that persisted once the recipient seroconverted. A codon 215 mutation (indicative of zidovudine resistance) was present in SI and NSI clones of the donor and in NSI clones of the recipient. The relative increase in codon 215 resistance mutation in the absence of zidovudine therapy was secondary to the increase in NSI clones. Findings in this case suggest that qualities of an inoculum and/or the route of transmission are important determinants in the subsequent clinical course of HIV disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527543     DOI: 10.1093/clinids/21.3.556

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay.

Authors:  J A Nelson; S A Fiscus; R Swanstrom
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 2.  Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1).

Authors:  B J Doranz; J F Berson; J Rucker; R W Doms
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

Review 3.  Antiviral drug resistance.

Authors:  D Pillay; M Zambon
Journal:  BMJ       Date:  1998-09-05

4.  Molecular investigation of transmission of human immunodeficiency virus type 1 in a criminal case.

Authors:  R Machuca; L B Jørgensen; P Theilade; C Nielsen
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

5.  No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1.

Authors:  F A Koning; D Schols; H Schuitemaker
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.

Authors:  Evelien M Bunnik; Esther D Quakkelaar; Ad C van Nuenen; Brigitte Boeser-Nunnink; Hanneke Schuitemaker
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.

Authors:  Susan J Little; Simon D W Frost; Joseph K Wong; Davey M Smith; Sergei L Kosakovsky Pond; Caroline C Ignacio; Neil T Parkin; Christos J Petropoulos; Douglas D Richman
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

8.  Molecular analysis of HIV strains from a cluster of worker infections in the adult film industry, Los Angeles 2004.

Authors:  John T Brooks; Kenneth E Robbins; Ae S Youngpairoj; Harlan Rotblatt; Peter R Kerndt; Melanie M Taylor; Eric S Daar; Marcia L Kalish
Journal:  AIDS       Date:  2006-04-04       Impact factor: 4.177

9.  Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.

Authors:  J Gerardo García-Lerma; Hamish MacInnes; Diane Bennett; Hillard Weinstock; Walid Heneine
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC).

Authors:  J García Lerma; R F Schinazi; A S Juodawlkis; V Soriano; Y Lin; K Tatti; D Rimland; T M Folks; W Heneine
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.